| 000 | 01822nam a2200493 a 4500 | ||
|---|---|---|---|
| 005 | 20250919174708.0 | ||
| 006 | m d | ||
| 007 | cr nn 008maaau | ||
| 008 | 100623s2009 sz j eng d | ||
| 020 | _a9783764386986 (electronic bk.) | ||
| 020 | _a9783764386948 (paper) | ||
| 035 | _a(Springer)978-3-7643-8694-8 | ||
| 039 | 9 |
_y06-23-2010 _zmuhaimin |
|
| 082 | 0 | 4 |
_a612.111 _222 |
| 090 | _aebook | ||
| 245 | 0 | 0 |
_aErythropoietins, erythropoietic factors, and erythropoiesis _h[electronic resource] : _bmolecular, cellular, preclinical, and clinical biology / _cedited by Steven G. Elliott, Mary Ann Foote, Graham Molineux. |
| 250 | _a2nd rev. and ext. ed. | ||
| 260 |
_aBasel : _bBirkhauser Basel, _c2009. |
||
| 300 |
_axviii, 326 p. : _bill. (some col.), digital ; _c24 cm. |
||
| 440 | 0 | _aMilestones in drug therapy | |
| 650 | 0 | _aErythropoietin. | |
| 650 | 0 |
_aErythropoietin _xTherapautic use. |
|
| 650 | 0 | _aErythropoiesis. | |
| 650 | 0 |
_aErythropoiesis _xMolecular aspects. |
|
| 650 | 0 |
_aAnemia _xTreatment. |
|
| 650 | 1 | 4 | _aBiomedicine. |
| 650 | 2 | 4 | _aCell Biology. |
| 650 | 2 | 4 | _aSports Medicine. |
| 650 | 2 | 4 | _aEndocrinology. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 700 | 1 | _aFoote, Mary Ann. | |
| 700 | 1 | _aMolineux, Graham. | |
| 700 | 1 | _aElliott, Steven G. | |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 856 | 4 | 0 | _uhttps://doi-org.eresourcesptsl.ukm.remotexs.co/10.1007/978-3-7643-8698-6 |
| 856 | 4 | 0 | _uhttps://link-springer-com.eresourcesptsl.ukm.remotexs.co/book/10.1007/978-3-7643-8698-6 |
| 907 |
_a.b14749920 _b2023-12-11 _c2019-11-12 |
||
| 942 |
_n0 _kebook |
||
| 914 | _avtls003435929 | ||
| 998 |
_ah _b2010-10-06 _cm _dz _feng _gsz _y0 _z.b14749920 |
||
| 999 |
_c678475 _d678475 |
||